These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 22884636)

  • 1. Effect of intratympanic dexamethasone administration on cisplatin-induced ototoxicity in adult guinea pigs.
    Shafik AG; Elkabarity RH; Thabet MT; Soliman NB; Kalleny NK
    Auris Nasus Larynx; 2013 Feb; 40(1):51-60. PubMed ID: 22884636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The protective effect of intratympanic dexamethasone on cisplatin-induced ototoxicity in guinea pigs.
    Daldal A; Odabasi O; Serbetcioglu B
    Otolaryngol Head Neck Surg; 2007 Nov; 137(5):747-52. PubMed ID: 17967639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intratympanic dexamethasone to prevent cisplatin ototoxicity: a guinea pig model.
    Murphy D; Daniel SJ
    Otolaryngol Head Neck Surg; 2011 Sep; 145(3):452-7. PubMed ID: 21521888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can intratympanic dexamethasone protect against cisplatin ototoxicity in mice with age-related hearing loss?
    Parham K
    Otolaryngol Head Neck Surg; 2011 Oct; 145(4):635-40. PubMed ID: 21572077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are intratympanic injections of N-acetylcysteine and methylprednisolone protective against Cisplatin-induced ototoxicity?
    Saliba I; El Fata F; Ouelette V; Robitaille Y
    J Otolaryngol Head Neck Surg; 2010 Jun; 39(3):236-43. PubMed ID: 20470667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of intratympanic lactate injection in the prevention of cisplatin-induced ototoxicity.
    Nader ME; Théorêt Y; Saliba I
    Laryngoscope; 2010 Jun; 120(6):1208-13. PubMed ID: 20513041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dexamethasone-loaded chitosan-based genipin-cross-linked hydrogel for prevention of cisplatin induced ototoxicity in Guinea pig model.
    Yüksel Aslıer NG; Tağaç AA; Durankaya SM; Çalışır M; Ersoy N; Kırkım G; Yurdakoç K; Bağrıyanık HA; Yılmaz O; Sütay S; Güneri EA
    Int J Pediatr Otorhinolaryngol; 2019 Jul; 122():60-69. PubMed ID: 30974336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective role of resveratrol against cisplatin induced ototoxicity in guinea pigs.
    Yumusakhuylu AC; Yazici M; Sari M; Binnetoglu A; Kosemihal E; Akdas F; Sirvanci S; Yuksel M; Uneri C; Tutkun A
    Int J Pediatr Otorhinolaryngol; 2012 Mar; 76(3):404-8. PubMed ID: 22261612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Sustained-Exposure Dexamethasone Formulation OTO-104 Offers Effective Protection against Cisplatin-Induced Hearing Loss.
    Fernandez R; Harrop-Jones A; Wang X; Dellamary L; LeBel C; Piu F
    Audiol Neurootol; 2016; 21(1):22-9. PubMed ID: 26789647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dexamethasone otoprotection in a multidose cisplatin ototoxicity mouse model.
    Hughes AL; Hussain N; Pafford R; Parham K
    Otolaryngol Head Neck Surg; 2014 Jan; 150(1):115-20. PubMed ID: 24233060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dexamethasone loaded nanoparticles exert protective effects against Cisplatin-induced hearing loss by systemic administration.
    Sun C; Wang X; Chen D; Lin X; Yu D; Wu H
    Neurosci Lett; 2016 Apr; 619():142-8. PubMed ID: 26971701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is intratympanic injection of erdosteine protective against cisplatin-induced ototoxicity?
    Saliba I; El Fata F
    Neurotox Res; 2012 Apr; 21(3):302-8. PubMed ID: 21989624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of a dexamethasone-releasing implant on cochleae: A functional, morphological and pharmacokinetic study.
    Liu Y; Jolly C; Braun S; Janssen T; Scherer E; Steinhoff J; Ebenhoch H; Lohner A; Stark T; Kiefer J
    Hear Res; 2015 Sep; 327():89-101. PubMed ID: 25987502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the protective efficacy between intratympanic dexamethasone and resveratrol treatments against cisplatin-induced ototoxicity: an experimental study.
    Simsek G; Taş BM; Muluk NB; Azman M; Kılıç R
    Eur Arch Otorhinolaryngol; 2019 Dec; 276(12):3287-3293. PubMed ID: 31531774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cisplatin-induced ototoxicity: effect of intratympanic dexamethasone injections.
    Hill GW; Morest DK; Parham K
    Otol Neurotol; 2008 Oct; 29(7):1005-11. PubMed ID: 18716567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic dexamethasone for the prevention of cisplatin-induced ototoxicity.
    Waissbluth S; Salehi P; He X; Daniel SJ
    Eur Arch Otorhinolaryngol; 2013 May; 270(5):1597-605. PubMed ID: 22907029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of antioxidants in protection from ototoxic drugs.
    Sergi B; Fetoni AR; Ferraresi A; Troiani D; Azzena GB; Paludetti G; Maurizi M
    Acta Otolaryngol Suppl; 2004 May; (552):42-5. PubMed ID: 15219046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of 2 Different Intratympanic Steroid Regimen on Prevention of Cisplatin Ototoxicity: An Experimental Study.
    Taş BM; Şimşek G; Azman M; Kılıç R
    Ear Nose Throat J; 2021 Jul; 100(6):417-422. PubMed ID: 31569969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Round window delivery of dexamethasone ameliorates local and remote hearing loss produced by cochlear implantation into the second turn of the guinea pig cochlea.
    Eastwood H; Chang A; Kel G; Sly D; Richardson R; O'Leary SJ
    Hear Res; 2010 Jun; 265(1-2):25-9. PubMed ID: 20303400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimal N-acetylcysteine concentration for intratympanic injection to prevent cisplatin-induced ototoxicity in guinea pigs.
    Chen BC; Lin LJ; Lin YC; Lee CF; Hsu WC
    Acta Otolaryngol; 2022 Feb; 142(2):127-131. PubMed ID: 35287541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.